[go: up one dir, main page]

BR9609137A - Dispositivo para liberação de eletro-transporte transdérmico de fentanyl e sufentanil - Google Patents

Dispositivo para liberação de eletro-transporte transdérmico de fentanyl e sufentanil

Info

Publication number
BR9609137A
BR9609137A BR9609137A BR9609137A BR9609137A BR 9609137 A BR9609137 A BR 9609137A BR 9609137 A BR9609137 A BR 9609137A BR 9609137 A BR9609137 A BR 9609137A BR 9609137 A BR9609137 A BR 9609137A
Authority
BR
Brazil
Prior art keywords
sufentanil
fentanyl
release
transdermal electrotransport
electrotransport
Prior art date
Application number
BR9609137A
Other languages
English (en)
Other versions
BR9609137B1 (pt
Inventor
Mary Southam
Keith J Bernstein
Henk Noorduin
Joseph B Phipps
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23848034&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9609137(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of BR9609137A publication Critical patent/BR9609137A/pt
Publication of BR9609137B1 publication Critical patent/BR9609137B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Electrotherapy Devices (AREA)
BRPI9609137-1A 1995-06-05 1996-06-05 dispositivo para liberação de eletrotransporte transdérmico de fentanil e sufentanil. BR9609137B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/465,492 US6881208B1 (en) 1995-06-05 1995-06-05 Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
PCT/US1996/009264 WO1996039224A1 (en) 1995-06-05 1996-06-05 Device for transdermal electrotransport delivery of fentanyl and sufentanil

Publications (2)

Publication Number Publication Date
BR9609137A true BR9609137A (pt) 1999-02-17
BR9609137B1 BR9609137B1 (pt) 2010-06-29

Family

ID=23848034

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9609137-1A BR9609137B1 (pt) 1995-06-05 1996-06-05 dispositivo para liberação de eletrotransporte transdérmico de fentanil e sufentanil.

Country Status (20)

Country Link
US (3) US6881208B1 (pt)
JP (3) JPH11506684A (pt)
KR (1) KR100431364B1 (pt)
CN (1) CN1118308C (pt)
AT (1) AT409088B (pt)
AU (1) AU695465B2 (pt)
BE (1) BE1009505A3 (pt)
BR (1) BR9609137B1 (pt)
CA (2) CA2219736C (pt)
CH (1) CH690751A5 (pt)
DE (1) DE19681420B4 (pt)
FR (1) FR2736837B1 (pt)
GB (1) GB2317115B (pt)
GR (1) GR1002982B (pt)
IE (1) IE960374A1 (pt)
IT (1) IT1285387B1 (pt)
NL (1) NL1003274C2 (pt)
SE (1) SE521220C2 (pt)
WO (1) WO1996039224A1 (pt)
ZA (1) ZA964658B (pt)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881208B1 (en) * 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
PT1051220E (pt) 1998-01-28 2005-02-28 Alza Corp Conjunto de electrodo de electrotransporte com fraca resistencia inicial
US6858018B1 (en) 1998-09-28 2005-02-22 Vyteris, Inc. Iontophoretic devices
IL142808A0 (en) 1998-11-02 2002-03-10 Alza Corp Electrotransport device including a compatible antimicrobial agent
US6541021B1 (en) * 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US6496727B1 (en) * 2000-05-31 2002-12-17 Becton, Dickinson And Company Medicament-loaded transdermal reservoir and method for its formation
KR100888275B1 (ko) 2000-07-31 2009-03-10 니코메드 댄마크 에이에스 코 투여용 펜타닐 조성물
MXPA03002177A (es) * 2000-09-11 2004-12-13 Johnson & Johnson Dispositivo de electrotransporte transdermico y metodo para fabricar el mismo.
KR100856693B1 (ko) 2001-04-04 2008-09-04 알자 코포레이션 항미생물제 양립가능성 저장소 조성물을 포함하는 경피전기수송 전달 장치
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
WO2004002571A1 (en) * 2002-06-28 2004-01-08 Alza Corporation A reservoir for use in an electrotransport drug delivery device
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8357114B2 (en) * 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8252329B2 (en) * 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8252328B2 (en) 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US20070299687A1 (en) * 2006-06-23 2007-12-27 Pamela Palmer Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed
US20080009782A1 (en) * 2006-06-28 2008-01-10 Alza Corporation Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
US20080004671A1 (en) * 2006-06-28 2008-01-03 Alza Corporation Vagus nerve stimulation via orally delivered apparatus
KR100730582B1 (ko) * 2006-11-20 2007-06-20 아람휴비스(주) 이온토포레시스 장치
EP2101864A2 (en) * 2006-12-20 2009-09-23 ALZA Corporation Anode for electrotransport of cationic drug
EP2043733A1 (en) * 2007-06-26 2009-04-08 Alza Corporation Methods and devices for transdermal electrotransport delivery of lofentanil and carfentanil
US20090105634A1 (en) * 2007-10-17 2009-04-23 Alza Corporation Anodic Reservoir for Electrotransport of Cationic Drug
US20090105632A1 (en) * 2007-10-18 2009-04-23 Padmanabhan Rama V Electrotransport Of Lisuride
WO2009123970A2 (en) * 2008-04-01 2009-10-08 Alza Corporation Electrotransport fentanyl delivery device with consistent delivery
WO2009158032A1 (en) * 2008-06-25 2009-12-30 Fe2, Inc. Patches and methods for the transdermal delivery of a therapeutically effective amount of iron
US20100004583A1 (en) * 2008-07-01 2010-01-07 Alza Corporation Hydrophobic Circuit Board Coating of Electrotransport Drug Delivery Devices
KR101267737B1 (ko) * 2008-09-02 2013-05-24 테이코쿠 팔마 유에스에이, 인코포레이티드 장시간의 이온토포레시스 적용 기간에 적합한 희생 전극 디자인 및 전달 종
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
EP2393549B1 (en) 2008-12-30 2014-10-01 NuPathe Inc. Electronic control of drug delivery system
US8190252B2 (en) 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
US8961492B2 (en) 2009-02-12 2015-02-24 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
US8548623B2 (en) 2009-03-18 2013-10-01 Acelrx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
JP2012524604A (ja) * 2009-04-25 2012-10-18 インキューブ ラブズ， エルエルシー キレート剤の経皮的イオン導入送達のための方法
US8821945B2 (en) 2009-04-25 2014-09-02 Fe3 Medical, Inc. Method for transdermal iontophoretic delivery of chelated agents
WO2011044175A2 (en) 2009-10-06 2011-04-14 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
WO2011100376A2 (en) 2010-02-10 2011-08-18 Incube Labs, Llc Methods and architecture for power optimization of iontophoretic transdermal drug delivery
CN107115326B (zh) 2010-04-13 2021-01-22 雷尔玛达治疗股份有限公司 1-甲基-n-(2,6-二甲苯基)-2-哌啶甲酰胺的皮肤用药物组合物及其使用方法
JP2013543773A (ja) 2010-11-23 2013-12-09 ニューパス インコーポレーテッド 利用者により活性化される自己充足型の共にパッケージされたイオントフォレーシス薬剤送達システム
WO2012129576A2 (en) 2011-03-24 2012-09-27 Incube Labs, Llc System and method for biphasic transdermal iontophreotic delivery of therapeutic agents
US8428708B1 (en) 2012-05-21 2013-04-23 Incline Therapeutics, Inc. Self-test for analgesic product
US8428709B1 (en) 2012-06-11 2013-04-23 Incline Therapeutics, Inc. Current control for electrotransport drug delivery
WO2012154704A2 (en) 2011-05-06 2012-11-15 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
WO2013156850A1 (en) 2012-04-17 2013-10-24 Purdue Pharma L.P. Systems and methods for treating an opioid-induced adverse pharmacodynamic response
BR112017013311B1 (pt) 2014-12-23 2022-05-31 Acelrx Pharmaceuticals, Inc Aparelho para a dispensação de formas de dosagem via oral e transmucosal
KR20250166945A (ko) 2023-03-28 2025-11-28 기꼬만 가부시키가이샤 경피 통전 패치

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141359A (en) 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4856188A (en) 1984-10-12 1989-08-15 Drug Delivery Systems Inc. Method for making disposable and/or replenishable transdermal drug applicators
US5224928A (en) 1983-08-18 1993-07-06 Drug Delivery Systems Inc. Mounting system for transdermal drug applicator
US5135479A (en) 1983-08-18 1992-08-04 Drug Delivery Systems, Inc. Programmable control and mounting system for transdermal drug applicator
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US5135477A (en) 1984-10-29 1992-08-04 Medtronic, Inc. Iontophoretic drug delivery
US4752285B1 (en) 1986-03-19 1995-08-22 Univ Utah Res Found Methods and apparatus for iontophoresis application of medicaments
US5080646A (en) 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US4931046A (en) * 1987-05-15 1990-06-05 Newman Martin H Iontophoresis drug delivery system
US5006108A (en) 1988-11-16 1991-04-09 Noven Pharmaceuticals, Inc. Apparatus for iontophoretic drug delivery
US5320597A (en) 1991-02-08 1994-06-14 Becton, Dickinson And Company Device and method for renewing electrodes during iontophoresis
US5232448A (en) 1989-12-05 1993-08-03 Prime Medical Products Patient-controlled analgesia device
US5167616A (en) 1989-12-14 1992-12-01 Alza Corporation Iontophoretic delivery method
IT1244030B (it) 1989-12-21 1994-06-28 Elan Corp Plc Dispostitivo in due parti per la somministrazione controllata di un ingrediente
US5047007A (en) 1989-12-22 1991-09-10 Medtronic, Inc. Method and apparatus for pulsed iontophoretic drug delivery
AU657681B2 (en) * 1990-03-30 1995-03-23 Alza Corporation Device and method for iontophoretic drug delivery
US5125894A (en) * 1990-03-30 1992-06-30 Alza Corporation Method and apparatus for controlled environment electrotransport
US5224927A (en) 1990-11-01 1993-07-06 Robert Tapper Iontophoretic treatment system
US5254081A (en) 1991-02-01 1993-10-19 Empi, Inc. Multiple site drug iontophoresis electronic device and method
US5203768A (en) 1991-07-24 1993-04-20 Alza Corporation Transdermal delivery device
US5464387A (en) * 1991-07-24 1995-11-07 Alza Corporation Transdermal delivery device
US5246418A (en) 1991-12-17 1993-09-21 Becton Dickinson And Company Iontophresis system having features for reducing skin irritation
FR2687321B1 (fr) * 1992-02-14 1999-04-16 Elf Aquitaine Dispositif d'ionophorese pour l'administration transcutanee d'une quantite totale donnee d'un principe actif a un sujet.
US5298017A (en) 1992-12-29 1994-03-29 Alza Corporation Layered electrotransport drug delivery system
US7027859B1 (en) * 1994-09-26 2006-04-11 Alza Corporation Electrotransport delivery device having improved safety and reduced abuse potential
US5879322A (en) * 1995-03-24 1999-03-09 Alza Corporation Self-contained transdermal drug delivery device
US6881208B1 (en) * 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
US6216033B1 (en) * 1996-05-22 2001-04-10 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil

Also Published As

Publication number Publication date
CH690751A5 (de) 2001-01-15
SE9704103D0 (sv) 1997-11-10
DE19681420B4 (de) 2009-05-28
US20050171464A1 (en) 2005-08-04
BE1009505A3 (fr) 1997-04-01
CA2613061C (en) 2010-02-09
CA2219736C (en) 2008-02-12
AU695465B2 (en) 1998-08-13
JPH11506684A (ja) 1999-06-15
JP2007237002A (ja) 2007-09-20
GB9725542D0 (en) 1998-02-04
GB2317115A (en) 1998-03-18
GR960100178A (el) 1997-02-28
BR9609137B1 (pt) 2010-06-29
US6881208B1 (en) 2005-04-19
FR2736837A1 (fr) 1997-01-24
SE521220C2 (sv) 2003-10-14
KR100431364B1 (ko) 2004-07-16
GR1002982B (el) 1998-10-01
ATA903696A (de) 2001-10-15
KR19990022342A (ko) 1999-03-25
JP4616309B2 (ja) 2011-01-19
ZA964658B (en) 1997-02-03
GB2317115B (en) 1999-08-04
JP2005261970A (ja) 2005-09-29
ITTO960477A1 (it) 1997-12-03
NL1003274C2 (nl) 1998-11-03
DE19681420T1 (de) 1998-05-20
AT409088B (de) 2002-05-27
WO1996039224A1 (en) 1996-12-12
SE9704103L (sv) 1997-11-10
US20050131337A1 (en) 2005-06-16
CA2219736A1 (en) 1996-12-12
ITTO960477A0 (it) 1996-06-03
AU6257896A (en) 1996-12-24
FR2736837B1 (fr) 1998-07-24
CN1187142A (zh) 1998-07-08
CN1118308C (zh) 2003-08-20
NL1003274A1 (nl) 1996-12-06
CA2613061A1 (en) 1996-12-12
IE960374A1 (en) 1996-12-11
JP4070779B2 (ja) 2008-04-02
IT1285387B1 (it) 1998-06-03

Similar Documents

Publication Publication Date Title
BR9609137A (pt) Dispositivo para liberação de eletro-transporte transdérmico de fentanyl e sufentanil
FI974418L (fi) Laite fentanyylin ja sufentaniilin ihon kautta tapahtuvaan elektrokuljetusantoon
DE69713989D1 (de) Fentanyl enthaltendes transdermal-pflaster
DE69815291D1 (de) Sicherheitsgerät und verfahren
DE69826564D1 (de) Druckvorrichtung und Druckverfahren
FI962219L (fi) Laite aktiivisen aineen kontrolloiduksi vapauttamiseksi
FI955259L (fi) Estradiolia sisältävä transdermaalinen terapeuttinen systeemi
BR9610618A (pt) Aparelho e métodos para dispositivos de matriz progamáveis ativos
DE69824360D1 (de) Peripheriegerät und entsprechendes Verfahren
ATE253361T1 (de) Mittel zur gesteuerten freisetzung von paroxetin
DE69614654D1 (de) Verschlüsselungsgerät und -verfahren
BR9609138A (pt) Dispositivo para distribuição transdérmica por eletro-transporte de fentanil e sufentanil
DE69611922D1 (de) Elektro-mechanische sicherheits-und scharfvorrichtung
DE69840108D1 (de) Versuchsverfahren und vorrichtung
DE59500266D1 (de) Transdermales therapeutisches System zur Applikation von Naloxon
NO973471D0 (no) Transdermal formulering
UA10998C2 (uk) Спосіб поліфакторhої лікувальhої дії та ковдра для поліфакторhої лікувальhої дії
BR9607722A (pt) Formulação transdérmica
BR9608272A (pt) Metodo e dispositivo para liberar placas catodicas
KR970057131U (ko) 단조소재의 공급장치
SI0836511T1 (en) Device for transdermal electrotransport delivery of fentanyl and sufentanil
SE9700314D0 (sv) Method and device for therapy
BR9500775A (pt) Dispositivo de liberação de droga iontoforético composição e uso do referido dispositivo
SE9600181D0 (sv) Method and device for therapy
BR7502266U (pt) Dispositivo mecânico de proteção individual e resgate

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: A REQUERENTE DEVERA COMPLEMENTAR O VALOR DA TAXA DE EXAME REFERENTE AS REIVINDICACOES EXCEDENTES, PARA QUE SE DE PROSSEGUIMENTO AO EXAME TECNICO.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/06/2010, OBSERVADAS AS CONDICOES LEGAIS.

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI-52400.061204/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132250-71.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: ACINO PHARMA AG, ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND, AGOURON PHARMACEUTICALA, ALCON LABORATORIES , ALZA CORPORATION.

B24H Lapse because of non-payment of annual fees (definitively: art 78 iv lpi)

Free format text: EXTINCAO DEFINITIVA - ART. 78 INCISO IV DA LPI

B19A Notification of judicial decision: notification of judicial decision

Free format text: INPI-52400.61574/13 SECAO JUDICIARIA DO RIO DE JANEIRO - 13A VARA FEDERAL PROCESSO NO. 2013.51.01.132250-7 AUTOR: INPI-INSTITUTO NACIONAL DE PROPRIEDADE INDUSTRIAL REU(S): AGOURON PHARMACEUTICALS,INC, ACINO PHARMA AG, ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND, ALZA CORPORATION,ALCON LABORATORIES,INC . DECISAO: ISTO POSTO, HOMOLOGO OS ACORDOS FIRMADOS, JULGANDO EXTINTO O PROCESSO COM RESOLUCAO DE MERITO, FORTE NO ART.269,III DO CODIGO DE PROCESSO CIVIL.

B24F Patent annual fee: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2234 DE 29/10/2013 POR TER SIDO INDEVIDA.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTA AS ANUIDADES 16A ATE 20A.